Precedent Therapeutics Email Formats
Biotechnology Research • • 1-10 Employees
Key Contact at Precedent Therapeutics
Ron Wineinger
Chief Executive Officer
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
About Precedent Therapeutics
Precedent Therapeutics is an early-stage biotech focused on repurposing and reformulating off-patent, small molecules for traumatic and rare neurological conditions, like TBI (traumatic brain injury) and ALS (amyotrophic lateral sclerosis). These conditions have no therapeutic options or very marginally effective treatments.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Precedent Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Precedent Therapeutics has never raised funding before.
Chile
Spain
Frequently asked questions
Precedent Therapeutics is located in XX.
Precedent Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
Precedent Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
